Literature DB >> 21924771

Retrovirus-transformed erythroleukemia cells induce central nervous system failure in a new syngeneic mouse model of meningeal leukemia.

Gordon R Macpherson1, Charlotte A Hanson, Delores M Thompson, Christine M Perella, Joan L Cmarik, Sandra K Ruscetti.   

Abstract

Lack of suitable mouse models for central nervous system (CNS)-associated leukemias has hindered mechanism-guided development of therapeutics. By transplanting retrovirus-transformed mouse erythroleukemia cells into syngeneic mice, we developed a new animal model of meningeal leukemia associated with rapid paralysis. Necropsy revealed massive proliferation of the leukemic cells in the bone marrow (BM) followed by pathological angiogenesis and invasion of the leukemic cells into the meninges of the CNS. Further analysis demonstrated that the erythroleukemia cells secreted high levels of VEGF and preferentially adhered in vitro to fibronectin. This unique animal model for meningeal leukemia should facilitate studies of engraftment and proliferation of leukemic cells in the BM and their invasion of the CNS as well as pre-clinical evaluation of experimental therapeutics for CNS-associated leukemias. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924771      PMCID: PMC3264761          DOI: 10.1016/j.leukres.2011.08.019

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  40 in total

1.  Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow.

Authors:  Mo A Dao; Jan A Nolta
Journal:  Blood       Date:  2006-11-09       Impact factor: 22.113

Review 2.  PU.1: a crucial and versatile player in hematopoiesis and leukemia.

Authors:  Philippe Kastner; Susan Chan
Journal:  Int J Biochem Cell Biol       Date:  2007-02-04       Impact factor: 5.085

Review 3.  Critical determinants of metastasis.

Authors:  Isaiah J Fidler
Journal:  Semin Cancer Biol       Date:  2002-04       Impact factor: 15.707

Review 4.  Neurologic complications of leukemia.

Authors:  Alexis Demopoulos; Lisa M DeAngelis
Journal:  Curr Opin Neurol       Date:  2002-12       Impact factor: 5.710

5.  CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia.

Authors:  Silvia Buonamici; Thomas Trimarchi; Maria Grazia Ruocco; Linsey Reavie; Severine Cathelin; Brenton G Mar; Apostolos Klinakis; Yevgeniy Lukyanov; Jen-Chieh Tseng; Filiz Sen; Eric Gehrie; Mengling Li; Elizabeth Newcomb; Jiri Zavadil; Daniel Meruelo; Martin Lipp; Sherif Ibrahim; Argiris Efstratiadis; David Zagzag; Jonathan S Bromberg; Michael L Dustin; Iannis Aifantis
Journal:  Nature       Date:  2009-06-18       Impact factor: 49.962

6.  Central nervous system imaging in childhood leukaemia.

Authors:  L Porto; M Kieslich; D Schwabe; F E Zanella; H Lanfermann
Journal:  Eur J Cancer       Date:  2004-09       Impact factor: 9.162

7.  Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital.

Authors:  A W Walter; M L Hancock; C H Pui; M M Hudson; J S Ochs; G K Rivera; C B Pratt; J M Boyett; L E Kun
Journal:  J Clin Oncol       Date:  1998-12       Impact factor: 44.544

8.  The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1.

Authors:  R Paul; S Schuetze; S L Kozak; C A Kozak; D Kabat
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.

Authors:  Heike Pfeifer; Barbara Wassmann; Wolf-Karsten Hofmann; Martina Komor; Urban Scheuring; Patrick Brück; Anja Binckebanck; Eberhard Schleyer; Nicola Gökbuget; Thomas Wolff; Michael Lübbert; Lothar Leimer; Harald Gschaidmeier; Dieter Hoelzer; Oliver G Ottmann
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

Review 10.  Contribution of bone microenvironment to leukemogenesis and leukemia progression.

Authors:  F Ayala; R Dewar; M Kieran; R Kalluri
Journal:  Leukemia       Date:  2009-09-03       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.